Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. sophomore Avg
|
|
New words:
abdominal, abroad, abuse, accessing, admission, allegedly, Allogeneic, altogether, anemia, Anguilla, antithymocyte, Arab, Arabia, Argentina, arsenic, article, ascribed, assert, ATG, ATRA, Austria, avoid, baseline, Bay, Belgium, brand, branded, breakdown, British, Bulgaria, Bulletin, buy, catastrophic, caution, Cayman, cDNA, cited, citizen, closure, cm, CMML, cohort, constipation, contact, convenient, costal, Croatia, cyclosporine, cytarabine, cytogenetic, Czech, Dacogen, danazol, daunorubicin, DBA, deacetylase, debilitating, deciliter, Denmark, density, diarrhea, died, difficulty, disagree, disappearance, disaster, discomfort, drenching, earthquake, EHA, estate, Estonia, exam, expansion, extramedullary, fashion, fault, feedback, fever, Finland, flawed, FLT, France, fraud, gap, globulin, gram, Greece, Guam, Guernsey, heat, hedgehog, hemoglobin, hepatomegaly, hepatotoxicity, hepatoxicity, hindered, histone, host, Hungary, hypomethylating, idarubicin, immunomodulatory, impeding, impossible, impracticable, ineffective, inMayo, intangible, intensified, interdependent, intracranial, intrusion, Ireland, irradiation, Israel, IST, itching, justify, landlord, Latvia, Lebanon, leukopenia, LFT, Liechtenstein, Likewise, Luxembourg, Malta, MDS, mechanistic, Medicaid, megakaryocyte, metabolite, Mexico, misappropriated, mitigate, MM, momelitinib, Monaco, morphologic, morphology, mTOR, myelomonocytic, myelosuppression, myelosuppressive, Myriad, nausea, neutrophil, night, nonfinancial, nonmonetary, Norway, older, onsite, orally, orderly, OTC, outlined, outpatient, owner, pacritinib, palpable, palpation, Panama, partnership, pathologic, pathological, pathology, payor, pegylated, penny, pentraxin, permission, pharmacoeconomic, physical, pilot, PMF, Poland, pomalidomide, Portugal, preclude, precluded, preferential, pressure, printing, Prognostic, Puerto, qualification, quantity, rational, recourse, refundable, regression, Republic, reside, resident, residing, retinoic, retreatment, Revlimid, Rico, ringed, Romania, safer, Sanofi, satiety, Saudi, Scoring, sequestration, shift, shock, Singapore, Slovakia, Slovenia, Spain, splenectomy, splenic, splenomegaly, staffing, statute, stopped, stringent, surrendered, Sweden, Switzerland, symptom, Taiwan, taxation, terrorism, therefrom, threat, threshold, tip, transformation, transformed, treaty, trioxide, trust, tyrosine, unacceptable, understood, undetermined, unexplained, unlawful, urged, Uruguay, verification, verified, verify, Vidaza, Virgin, vomiting, vulnerable, waiting, weaken
Removed:
accidental, affordability, agriculture, Alumni, appealed, Australian, BBB, behalf, bevacizumab, biosimilar, Birmingham, BRC, cartilage, CEO, charged, confidence, consumer, contamination, creating, cytotoxic, Danish, dendritic, Dentistry, differentiation, Doctorate, dopaminergic, driven, economy, Edinburgh, endoderm, escalation, ethical, excise, exclusively, exclusivity, expanding, facilitating, federally, feeder, fellow, fibrotic, fluctuation, formed, Foundation, Fox, funded, Genentech, glioblastoma, goal, greatly, growing, heart, hedging, hESC, Hospital, illustrate, imposing, incorporating, induction, innovative, instability, islet, KAEL, Kelsey, Korean, landscape, launched, lecturer, liable, licensor, London, MCC, Milan, Moral, multiforme, muscle, negotiate, nerve, neural, Norwegian, Ontario, Oxford, pancreatic, parallel, patentability, patented, Pharmacia, poor, potency, PPACA, processed, progressed, propose, QTDP, Qualifying, reach, reexamination, rejected, rejecting, renamed, restructure, Royal, ruled, shareholder, St, Steering, sublicense, SUGEN, susceptible, TAT, taxane, TBA, tested, titled, tolerated, translate, unchanged, underpayment, understand, unemployment, unique, uphold, upholding, Vancouver, visiting, WARF, Watchdog, Western, Wisconsin
Filing tables
Filing exhibits
GERN similar filings
Filing view
External links
QuickLinks -- Click here to rapidly navigate through this document
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Pursuant to 18 U.S.C. Section 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Geron Corporation (the "Company") hereby certifies, to such officer's knowledge, that:
- (i)
- the accompanying annual report on Form 10-K of the Company for the year ended December 31, 2013 (the "Report") fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and
- (ii)
- the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| Dated: March 17, 2014 | /s/ JOHN A. SCARLETT JOHN A. SCARLETT, M.D. President and Chief Executive Officer |
This certification accompanies the Form 10-K to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Form 10-K), irrespective of any general incorporation language contained in such filing.
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002